Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-027199
Filing Date
2023-05-03
Accepted
2023-05-03 20:59:51
Documents
1
Period of Report
2023-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7556
  Complete submission text file 0001209191-23-027199.txt   9304
Mailing Address DAMONMILL SQUARE SUITE 6A CONCORD MA 01742
Business Address
Geffken Daniel E. (Reporting) CIK: 0001314756 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39538 | Film No.: 23886063

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations